NZ334341A - Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase - Google Patents
Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferaseInfo
- Publication number
- NZ334341A NZ334341A NZ334341A NZ33434197A NZ334341A NZ 334341 A NZ334341 A NZ 334341A NZ 334341 A NZ334341 A NZ 334341A NZ 33434197 A NZ33434197 A NZ 33434197A NZ 334341 A NZ334341 A NZ 334341A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- aryl
- represent
- independently
- substituted
- Prior art date
Links
- 102000004357 Transferases Human genes 0.000 title abstract 2
- 108090000992 Transferases Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- XYNHQVIVVBWVAG-UHFFFAOYSA-N 4h-cyclohepta[f]quinoline Chemical class C1=CC=CC=C2C3=CC=CNC3=CC=C21 XYNHQVIVVBWVAG-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 12
- 125000003118 aryl group Chemical group 0.000 abstract 9
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 4
- 125000001475 halogen functional group Chemical group 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- -1 benzotriazol-1-yloxy, tetrazol-5-ylthio Chemical group 0.000 abstract 3
- 125000004404 heteroalkyl group Chemical group 0.000 abstract 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 3
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 101000599004 Homo sapiens Olfactory receptor 3A1 Proteins 0.000 abstract 1
- 102100037784 Olfactory receptor 3A1 Human genes 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71370596A | 1996-09-13 | 1996-09-13 | |
| PCT/US1997/015902 WO1998011097A1 (en) | 1996-09-13 | 1997-09-11 | Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ334341A true NZ334341A (en) | 2001-01-26 |
Family
ID=24867191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ334341A NZ334341A (en) | 1996-09-13 | 1997-09-11 | Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0931077B1 (enExample) |
| JP (1) | JP2001500506A (enExample) |
| KR (1) | KR20000036102A (enExample) |
| CN (1) | CN1104428C (enExample) |
| AT (1) | ATE294172T1 (enExample) |
| AU (1) | AU4337597A (enExample) |
| CA (1) | CA2264666A1 (enExample) |
| DE (1) | DE69733142T2 (enExample) |
| ES (1) | ES2242232T3 (enExample) |
| HU (1) | HUP0000073A3 (enExample) |
| IL (1) | IL128926A0 (enExample) |
| NZ (1) | NZ334341A (enExample) |
| WO (1) | WO1998011097A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613905B1 (en) | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| HUP0101320A3 (en) | 1998-01-21 | 2002-11-28 | Kyowa Hakko Kogyo Kk | Benzo- and pyridobenzoxepine and -benzazepine derivatives and use thereof |
| CA2318088A1 (en) | 1998-01-21 | 1999-07-29 | Yoshisuke Nakasato | Chemokine receptor antagonists and methods of use therefor |
| US6509346B2 (en) | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6288083B1 (en) | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6503926B2 (en) | 1998-09-04 | 2003-01-07 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US7271176B2 (en) | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
| US7541365B2 (en) | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
| WO2005017160A2 (en) | 2003-08-13 | 2005-02-24 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
| RU2408584C2 (ru) | 2005-06-23 | 2011-01-10 | Мерк Шарп Энд Домэ Корп. | Ингибиторы тирозинкиназы |
| TW200813021A (en) | 2006-07-10 | 2008-03-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
| JP5448164B2 (ja) | 2006-07-28 | 2014-03-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体を変調する化合物 |
| WO2009061652A1 (en) | 2007-11-07 | 2009-05-14 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
| WO2010005782A1 (en) | 2008-07-10 | 2010-01-14 | Boehringer Ingelheim International Gmbh | Sulfone compounds which modulate the cb2 receptor |
| AP2011005674A0 (en) | 2008-09-25 | 2011-04-30 | Boehringer Ingelheim Int | Sulfonyl compounds which selectively modulate the CB2 receptor. |
| WO2010096371A2 (en) | 2009-02-18 | 2010-08-26 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds which modulate the cb2 receptor |
| US8299103B2 (en) | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| US8383615B2 (en) | 2009-06-16 | 2013-02-26 | Boehringer Ingelheim International Gmbh | Azetidine 2-carboxamide derivatives which modulate the CB2 receptor |
| US8383651B2 (en) | 2009-09-22 | 2013-02-26 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| EP2523936A1 (en) | 2010-01-15 | 2012-11-21 | Boehringer Ingelheim International GmbH | Compounds which modulate the cb2 receptor |
| US8329735B2 (en) | 2010-03-05 | 2012-12-11 | Boehringer Ingelheim International Gmbh | Tetrazole compounds which selectively modulate the CB2 receptor |
| EP2595959B1 (en) | 2010-07-22 | 2015-11-04 | Boehringer Ingelheim International GmbH | Sulfonyl compounds which modulate the cb2 receptor |
| EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1593417A (en) * | 1976-12-22 | 1981-07-15 | Squibb & Sons Inc | Carbocyclic-fused pyrazolopyridine derivatives |
| US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
| IL98572A (en) * | 1990-06-22 | 1995-07-31 | Schering Corp | Bis-benzo or benzopyrido cyclohepta piperidene, piperidylidene and piperazine compositions an methods of use |
| EP0723538B1 (en) * | 1993-10-15 | 2001-12-12 | Schering Corporation | Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
-
1997
- 1997-09-11 KR KR1019997002121A patent/KR20000036102A/ko not_active Withdrawn
- 1997-09-11 CN CN97199528A patent/CN1104428C/zh not_active Expired - Fee Related
- 1997-09-11 ES ES97941476T patent/ES2242232T3/es not_active Expired - Lifetime
- 1997-09-11 NZ NZ334341A patent/NZ334341A/xx unknown
- 1997-09-11 JP JP10513761A patent/JP2001500506A/ja not_active Ceased
- 1997-09-11 IL IL12892697A patent/IL128926A0/xx unknown
- 1997-09-11 CA CA002264666A patent/CA2264666A1/en not_active Abandoned
- 1997-09-11 WO PCT/US1997/015902 patent/WO1998011097A1/en not_active Ceased
- 1997-09-11 AT AT97941476T patent/ATE294172T1/de not_active IP Right Cessation
- 1997-09-11 HU HU0000073A patent/HUP0000073A3/hu unknown
- 1997-09-11 DE DE69733142T patent/DE69733142T2/de not_active Expired - Fee Related
- 1997-09-11 AU AU43375/97A patent/AU4337597A/en not_active Abandoned
- 1997-09-11 EP EP97941476A patent/EP0931077B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU4337597A (en) | 1998-04-02 |
| ATE294172T1 (de) | 2005-05-15 |
| WO1998011097A1 (en) | 1998-03-19 |
| EP0931077A1 (en) | 1999-07-28 |
| CN1104428C (zh) | 2003-04-02 |
| JP2001500506A (ja) | 2001-01-16 |
| CA2264666A1 (en) | 1998-03-19 |
| EP0931077B1 (en) | 2005-04-27 |
| HUP0000073A3 (en) | 2002-02-28 |
| KR20000036102A (ko) | 2000-06-26 |
| DE69733142D1 (de) | 2005-06-02 |
| IL128926A0 (en) | 2000-02-17 |
| ES2242232T3 (es) | 2005-11-01 |
| DE69733142T2 (de) | 2006-03-16 |
| HUP0000073A2 (hu) | 2001-10-28 |
| CN1236365A (zh) | 1999-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ334341A (en) | Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase | |
| NZ334453A (en) | Tricyclic inhibitors of farnesyl protein transferase | |
| NZ334452A (en) | Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase (FTase) | |
| ES479908A1 (es) | Procedimiento para preparar fosfonatos de pentaeritritilo. | |
| NZ334454A (en) | substituted benzocycloheptapyridine derivatives and medicaments | |
| GB1036578A (en) | Tertiary amine salts of phosphoric acid esters | |
| BG60165B2 (bg) | Метод за получаване на соли на n-фосфонометилглицина | |
| ATE222258T1 (de) | Herstellung von phosphin-liganden | |
| ATE13290T1 (de) | Verfahren zur n-alkylierung von organischen, stickstoffhaltigen verbindungen. | |
| DK603585A (da) | Fremgangsmaade til fremstilling af n-sulfonyl-(n-(phosphono-methyl)-glycyl)-amin-derivater | |
| NZ334451A (en) | Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase | |
| GB1312211A (en) | Phosphorus-containing dibromoeopentyl glycol ester derivatives | |
| DE69113659D1 (de) | Amine mit fungizider Wirkung. | |
| DK350588A (da) | Kvaterniserede nitrogenholdige forbindelser og fremgangsmaade til fremstilling af samme | |
| NZ334342A (en) | Compounds for inhibition of farnesyl protein transferase and the treatment of cancer | |
| ATE126813T1 (de) | Stabilisatoren für zusammensetzungen von ethylen/chlorotri- fluoroethylen copolymeren. | |
| FR2595360B1 (fr) | Composes du type cyclophosphazene, procede de preparation et composition pharmaceutique les contenant | |
| KR950011455A (ko) | 트리아릴포스파이트의 제조방법 | |
| GB1291853A (en) | Phenols | |
| ES295066A1 (es) | Procedimiento para la obtencion de ésteres del acido fosforico, fosfonico, fosfinico, tiofosforico, tionofosfonico y tionofosfinico | |
| GB1507317A (en) | Halogen-containing phosphoric esters | |
| JPS54157581A (en) | Oxazaphosphorine derivative | |
| ES295284A1 (es) | Procedimiento para la obtencion de ésteres del acido tiol o tionotiolfosforico, fosfonico o fosfinico | |
| HUP9801389A2 (hu) | Amin-oxid stabilizátor készítményt tartalmazó polimer készítmények | |
| ES295501A1 (es) | Procedimiento para la obtencion de ésteres del acido fosforico, fosfonico, fosfinico y tionofosforico, tionofosfonico y tionofosfinico |